1021 A pan-cancer signature identifies tumor-reacting CD8+ TILs and reveals their functional heterogeneity

Christopher Chamberlain; Arianna Draghi; Shawez Khan; Katja Harbst; Mario Presti; Aimilia Schina; Agnete Witness Præst Jensen; Anne-Christine Kiel Rasmussen; Torben Lorentzen; Jakob Vasehus Schou; Göran Jönsson; Inge Svane; Marco Donia

doi:10.1136/jitc-2022-SITC2022.1021

Article info

PDF

Regular and Young Investigator Award Abstracts

Immune Cell Types and Biology

1021 A pan-cancer signature identifies tumor-reacting CD8⁺ TILs and reveals their functional heterogeneity

Free

Authors

Christopher Chamberlain Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Arianna Draghi Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Shawez Khan Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Katja Harbst Lund University, Lund, Sweden PubMed articles Google scholar articles
Mario Presti Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Aimilia Schina Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Agnete Witness Præst Jensen Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Anne-Christine Kiel Rasmussen Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Torben Lorentzen Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Jakob Vasehus Schou Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Göran Jönsson Lund University, Lund, Sweden PubMed articles Google scholar articles
Inge Svane Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles
Marco Donia Copenhagen University Hospital, Herlev, Denmark PubMed articles Google scholar articles

Citation

Chamberlain C, Draghi A, Khan S, et al

1021 A pan-cancer signature identifies tumor-reacting CD8⁺ TILs and reveals their functional heterogeneity

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1021

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password